Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea

International Journal of Antimicrobial Agents

Volumn 39, Issue 1, 2012, Pages 81-85

  Park, Young Kyoung ^a   Jung, Sook In ^b   Park, Kyong Hwa ^b   Kim, Su Hwan ^a   Ko, Kwan Soo ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University   (South Korea)

^c Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

Acinetobacter nosocomialis; Acinetobacter pittii; bla IMP 1; bla SIM 1

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; IMIPENEM; MEROPENEM; OUTER MEMBRANE PROTEIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B; PROTEIN CARO; PROTEIN OPRD; RIFAMPICIN; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; UNCLASSIFIED DRUG;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER BEREZINIAE; ACINETOBACTER NOSOCOMIALIS; ACINETOBACTER PITTII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIAL GENE; BACTERIUM ISOLATION; BLAIMP 1 GENE; BLASIM 1 GENE; CONTROLLED STUDY; GENETIC IDENTIFICATION; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULSED FIELD GEL ELECTROPHORESIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SOUTH KOREA; SPECIES IDENTIFICATION;

ACINETOBACTER; ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTEREMIA; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; CARBAPENEMS; CROSS INFECTION; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; HUMANS; IMIPENEM; MICROBIAL SENSITIVITY TESTS; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; REPUBLIC OF KOREA;

EID: 82955237242     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2011.08.006     Document Type: Article

References (15)

1. Y.C. Lin, W.H. Sheng, Y.C. Chen, S.C. Chang, K.C. Hsia, and S.Y. Li Differences in carbapenem resistance genes among Acinetobacter baumannii, Acinetobacter genospecies 3 and Acinetobacter genospecies 13TU in Taiwan Int J Antimicrob Agents 35 2010 439 443
2. P. Espinal, I. Roca, and J. Vila Clinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter Future Microbiol 6 2011 495 511
3. A. Nemec, L. Krizova, M. Maixnerova, T.J. van der Reijden, P. Deschaght, and V. Passet Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU) Res Microbiol 162 2011 393 404
4. Y.C. Chuang, W.H. Sheng, S.Y. Li, Y.C. Lin, J.T. Wang, and Y.C. Chen Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia Clin Infect Dis 52 2011 352 360
5. Y.K. Park, S.I. Jung, K.H. Park, H.S. Cheong, K.R. Peck, and J.H. Song Independent emergence of colistin-resistant Acinetobacter spp. isolates from Korea Diagn Microbiol Infect Dis 64 2009 51 59
6. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-first informational supplement. Document M100-S21. Wayne, PA: CLSI; 2011.
7. A.Y. Peleg, J. Adams, and D.L. Paterson Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii Antimicrob Agents Chemother 51 2007 2065 2069 (Pubitemid 46903095)
8. G.H. Paul, P. Laurent, L. Marlene, Patrice, and S. Harald OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii Antimicrob Agents Chemother 53 2009 5035 5038
9. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea Antimicrob Agents Chemother 49 2005 4485 4491 (Pubitemid 41552576)
10. K. Lee, C.H. Lim, J.H. Cho, W.G. Lee, Y. Uh, and H.J. Kim High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004 Yonsei Med J 45 2006 634 645 (Pubitemid 44697294)
11. J.F. Turton, J. Shah, C. Ozongwu, and R. Pike Incidence of Acinetobacter species other than A. baumannii among clinical isolates of Acinetobacter: evidence for emerging species J Clin Microbiol 48 2010 1445 1449
12. G.D. Golanbar, C.K. Lam, Y.M. Chu, C. Cueva, S.W. Tan, and I. Silva Phenotypic and molecular characterization of Acinetobacter clinical isolates obtained from inmates of California correctional facilities J Clin Microbiol 49 2011 2121 2131
13. L.Y. Huang, P.L. Lu, T.L. Chen, F.Y. Chang, C.P. Fung, and L.K. Siu Molecular characterization of β-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan Antimicrob Agents Chemother 55 2010 2699 2703
14. C.K. Kim, Y. Lee, H. Lee, G.J. Woo, W. Song, and M.N. Kim Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182 Diagn Microbiol Infect Dis 68 2010 432 438
15. K. Lee, C.K. Kim, S.G. Hong, J. Choi, S. Song, and E. Koh Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases Int J Antimicrob Agents 36 2010 259 263